Chronic inflammation (inflammaging)

Inflammation is supposed to be a short, sharp emergency response that clears an infection and then shuts off; with age it stops shutting off, settling into a low, body-wide hum with no germ left to fight. This "inflammaging" ties heart disease, diabetes and dementia to a single shared mechanism — and it is unusually responsive to diet, exercise, sleep and stress.

Chronic inflammation, or inflammaging, is the eleventh of the twelve hallmarks of aging — an integrative hallmark, meaning it is less a root cause than a systemic consequence that then feeds back to accelerate everything upstream of it. Acute inflammation is one of the body's most useful tools: a self-limiting response that destroys pathogens, clears debris and triggers repair, then resolves. Inflammaging is what happens when that program never fully switches off — a sterile (germ-free), low-grade, persistent inflammatory state that pervades the tissues of older bodies and acts as both a symptom of aging and an active accelerant of it.^[1]

How confident should you be

Descriptive — Strong. Measurement — Strong as prediction, Moderate as a target. Lifestyle intervention — Moderate. Drugs — Weak, none established for healthy adults.

This is one of the better-supported hallmarks. That inflammation rises with age, that it comes from several converging sources, and that it predicts disease and death are all well established in large human cohorts — and unusually for this series, the headline finding rests on human data rather than mice. Measurement is a genuine strength: the markers are cheap, routine blood tests. Where confidence drops is causation and treatment. Most of the intervention evidence shows that behaviours which lower inflammatory markers also improve health, without establishing that the marker change is what did the work. And the pharmacological side is early: one flagship trial has never enrolled a participant, and another missed its primary endpoint.

What makes it "sterile," and why that matters

Strong. Settled immunology.

The defining oddity of inflammaging is that there is nothing to fight. Classic inflammation is launched when the immune system detects a pathogen. Inflammaging is launched by the body's own damaged components — molecules released by stressed and dying cells that the immune system mistakes for an infection. These internal alarm signals are called damage-associated molecular patterns (DAMPs), and the master switch they flip is a transcription factor known as NF-κB (nuclear factor kappa B), which coordinates the cell's entire pro-inflammatory program.^[2]

In a young body, NF-κB flares briefly and then resolves. In an aging body the upstream alarms never stop ringing, so it stays chronically switched on.^[3] That persistent, purposeless activation is the heart of the problem — and because the signals travel in the bloodstream, a process that begins as scattered local damage becomes a body-wide inflammatory tone.

The sources all converge

Strong. Each source below is independently well characterised; what remains uncertain is their relative contribution.

Inflammaging is not driven by one thing. It is the sum of several age-related failures that each pour the same inflammatory fuel into circulation, which is exactly why it sits at the integrative tier of the hallmarks framework.

Zombie cells. Senescent cells — damaged cells that stop dividing but refuse to die — secrete a continuous inflammatory cocktail (the senescence-associated secretory phenotype, or SASP) that both inflames the local tissue and converts healthy neighbours into more senescent cells. This is one of the largest single contributors; the full mechanism is covered under cellular senescence.^[4]
Leaked mitochondrial DNA. As the cell's power plants (mitochondria) accumulate damage and are cleared too slowly, they spill their own DNA into the cell interior. Because that DNA structurally resembles bacterial DNA, sensors that evolved to detect infection read it as one and fire — a thread that also runs through genomic instability.^[5]
An aging immune system. With age, blood-cell production skews toward pro-inflammatory cell types, the thymus shrinks and stops making fresh naive immune cells, and the repertoire fills with exhausted T-cells that have lost their ability to clear pathogens but still pump out inflammatory signals. This immunosenescence both fuels inflammaging and is worsened by it.^[6]
Visceral fat. Fat stored around the organs is an active inflammatory organ. As it expands, its resident immune cells switch from an anti-inflammatory to a pro-inflammatory state and secrete signalling proteins — interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-α) among them — directly into the bloodstream.^[7]
A leaky gut. The intestinal barrier weakens with age, letting fragments of gut bacteria cross into the circulation, where they continuously prod the innate immune system — the link to dysbiosis.^[8]

No single one of these explains inflammaging. Together they sustain it.

How systemic inflammation becomes disease

Moderate. The pathway is well worked out mechanistically and consistent with the epidemiology, but it is a mechanistic model rather than something a trial has tested end to end.

The reason inflammaging matters clinically is that it does not stay abstract — it converges on a shared pathway linking metabolic dysfunction, blood-vessel damage and brain decline. The hinge is insulin resistance and the health of the cells lining blood vessels, the endothelium.^[9]

In a healthy vessel, insulin signalling tells endothelial cells to produce nitric oxide, the molecule that relaxes and widens arteries, keeps blood from clotting inappropriately, and holds inflammation in check. Chronic inflammation selectively breaks the arm of insulin signalling that makes nitric oxide while leaving intact the arm that drives constriction — so vessels lose their relaxant and tilt toward stiffness, higher blood pressure, and the recruitment of inflammatory cells into the artery wall, where they help build atherosclerotic plaque.^[10]^[11] That is the mechanistic bridge from a diffuse inflammatory state to the hard cardiovascular outcomes covered under cholesterol and blood pressure, and it is the common pathway that ties obesity, hypertension and atherosclerosis together.^[12]

The same circulating signals reach the brain. They degrade the blood-brain barrier — the tight seal that normally keeps the brain's environment separate from the blood — allowing inflammatory molecules and immune cells to leak into brain tissue. There they activate the brain's resident immune cells into a self-perpetuating inflammatory state, and they induce insulin resistance in the brain itself, starving high-demand memory regions of fuel and promoting the tau and amyloid changes associated with Alzheimer's disease.^[13]^[14] This shared inflammatory-metabolic root is why the same lifestyle pattern tends to protect heart, metabolism and brain at once — the territory of dementia prevention.

Measuring it

Strong as prediction; Moderate as a target. The markers are validated against mortality in large human cohorts — this is the best-evidenced claim on the page. What they cannot yet tell you is whether changing them changes your outcome.

Inflammaging can be tracked cheaply, which makes it one of the more actionable hallmarks. The everyday clinical markers are high-sensitivity C-reactive protein (hs-CRP) and interleukin-6, both inexpensive blood tests of baseline inflammatory tone. A third, essentially free, is the neutrophil-to-lymphocyte ratio — calculable from any standard blood count — which rises with systemic stress, immune aging and frailty.^[15]^[16] Because single markers are noisy, researchers increasingly combine several into composite scores, and have built "inflammatory clocks" that read an entire network of immune signals to estimate immune age. The widely used epigenetic clock GrimAge has a second version that explicitly folds in a methylation-based estimate of C-reactive protein, tying epigenetic age directly to inflammatory status.^[17]

The most striking finding in this area is how powerful a plain inflammation score turns out to be. In 3,113 adults in the US Health and Retirement Study (mean age 68), researchers built a composite of seven inflammatory markers — including the same neutrophil-to-lymphocyte ratio available on any blood count — and compared it against thirteen DNA-methylation epigenetic clocks. The inflammation score tracked epigenetic age acceleration on ten of the thirteen, yet it still predicted four-year mortality after adjusting for them, implying it captures a distinct biological process. And it predicted death better than any of the thirteen clocks, better than obesity, and better than clinical multi-morbidity. Only chronological age itself did better.^[18]

Inflammation also independently predicts frailty, the geriatric syndrome of depleted physiological reserve, though that particular study was retrospective.^[19] For all the sophistication of the methylation clocks, a simple measure of how inflamed you are remains one of the strongest available reads on biological aging.

What actually lowers it

Diet — Moderate. Exercise — Moderate. Fasting schedules specifically — Weak. Stress and sleep — Weak.

This is where inflammaging is most encouraging: it responds to behaviour, and the levers are the familiar ones. A recurring lesson, though, is that the inflammatory benefit often tracks with weight loss and overall dietary quality rather than any single food or fasting schedule — so the honest framing is "patterns, not tricks."

An anti-inflammatory dietary pattern. Composite patterns beat isolated supplements. In a systematic review and meta-analysis of randomised trials, the Mediterranean diet significantly reduced circulating inflammatory markers versus control diets, while the DASH diet (Dietary Approaches to Stop Hypertension) and vegetarian and vegan patterns did not reach statistical significance in the same comparisons — likely reflecting heterogeneity in what those labels cover and smaller samples, but a useful reminder that "healthy-sounding" is not the same as "proven to lower inflammation."^[20] The practical version is the Mediterranean dietary pattern, and avoiding the pro-inflammatory drivers covered under ultra-processed food.^[21]

Two mechanisms inside that pattern are worth singling out. The marine omega-3 fats EPA and DHA (eicosapentaenoic and docosahexaenoic acid) do more than dampen inflammation — they are the raw material the body uses to build specialized pro-resolving mediators, signalling molecules that actively switch inflammation off and orchestrate clean-up rather than merely blocking it.^[22] (Dosing is covered under omega-3.) And dietary fibre feeds gut bacteria that ferment it into short-chain fatty acids, chiefly butyrate, which both calm immune signalling and serve as the primary fuel for the cells of the gut lining — shoring up the barrier whose breakdown leaks bacterial fragments into the blood.^[23] Fermented foods support the same axis.

Caloric restriction — with an honest caveat on fasting. Sustained moderate calorie restriction has the best evidence: the two-year CALERIE trial in healthy non-obese adults produced roughly a 10% reduction in body weight, significantly lowered TNF-α, and did so without adverse effects on quality of life. It also lowered active thyroid hormone — a real physiological trade-off, not a side note.^[24] The story for intermittent fasting is more equivocal: a 12-month randomised trial in adults with obesity found that time-restricted eating and standard calorie restriction produced similar weight loss but that neither significantly changed inflammatory cytokines by month 12.^[25] Reviews of the wider literature point the same way — the anti-inflammatory effect of fasting appears mainly when substantial weight is lost, and alternate-day fasting lowers C-reactive protein only once weight loss passes a meaningful threshold.^[26] The takeaway: the energy deficit and the fat loss are doing most of the work, not the clock.

Exercise — and the IL-6 paradox. This is the most counter-intuitive piece of the puzzle. Interleukin-6 is usually a villain of inflammaging — yet contracting muscle releases a burst of it into the blood during exercise, and this muscle-derived IL-6 is anti-inflammatory. It does not engage the damaging co-inflammatory route that immune-derived IL-6 takes; instead it triggers the rapid release of inflammation-resolving signals and suppresses production of TNF-α.^[27] Over time, regular training lowers baseline inflammation by shrinking visceral fat, quieting the inflammatory receptors on circulating immune cells, and shifting fat-tissue macrophages from a pro-inflammatory to a tissue-repairing state.^[28] The dose-response is hormetic, though: a single bout of exhaustive endurance exercise lasting hours triggers a transient pro-inflammatory, immunosuppressed state that can persist for a day, and chronic unrecovered overtraining can itself sustain inflammation — which is why recovery is part of the prescription, not an afterthought.^[29] The site covers practical dosing under zone 2, VO₂ max and resistance training.

Stress and sleep. Chronic psychological stress keeps the stress-hormone system switched on, and sustained cortisol exposure can make immune cells deaf to cortisol's normal anti-inflammatory feedback — removing one of the body's brakes on inflammation.^[30] Mindfulness-based stress reduction — the standard eight-week program of body-scan meditation, sitting meditation and mindful movement — has been associated with lower hs-CRP and other inflammatory markers in randomised trials, with larger reductions among people who practised more. The systematic review that collects those trials is careful about them, though: it found substantial heterogeneity and calls its own findings tentative and in need of replication.^[31] Adequate, consistent sleep is thought to preserve the same anti-inflammatory feedback; the broader picture lives under stress and recovery, and the direct sleep-and-senescence experiment under cellular senescence.

The drug frontier

Weak. None of these is established for healthy adults; all are covered in depth under geroprotectors.

Metformin, the long-standing diabetes drug, activates the cell's low-fuel sensor — the enzyme that switches on when energy runs short — and dampens NF-κB-driven inflammation.^[32] The large TAME trial (Targeting Aging with Metformin) was designed to test it for broad age-related disease prevention in non-diabetic older adults aged 65 to 79, partly to establish "aging" as a treatable indication with regulators.^[33] It has never been fully funded, and as of mid-2026 it has not enrolled a single participant — a proposal, not a study in progress, with nothing pending on it.
Rapamycin, given at low weekly doses to avoid the immune suppression of daily dosing, quiets the inflammatory secretome by inhibiting mTOR, the master nutrient-sensing pathway discussed under deregulated nutrient sensing.^[34] The PEARL trial (Participatory Evaluation of Aging with Rapamycin for Longevity) — 114 healthy adults, 48 weeks, randomised and placebo-controlled — is the best human evidence, and it should be read carefully: its primary outcome, a reduction in visceral fat, did not move at all (p = 0.942), and blood biomarkers stayed within normal ranges. Women on the higher weekly dose did gain lean tissue and report less pain, and the drug was well tolerated. One further caveat sits inside the trial: independent testing found the compounded rapamycin it used carried only about a third the bioavailability of generic sirolimus, so participants received meaningfully less drug than the labels implied.^[35]
Senolytics and senomorphics attack the SASP at its source, by clearing senescent cells or silencing their secretions. The human evidence — and the real cautions, including a study in which the popular dasatinib-plus-quercetin combination transiently accelerated several epigenetic-aging measures in healthy people — is laid out under cellular senescence.^[36]^[37]

What this does and doesn't tell you

What it tells you: inflammaging is a real, measurable and consequential process — the convergence point where senescent cells, leaked mitochondrial DNA, an aging immune system, visceral fat and a leaky gut all feed a single body-wide inflammatory state that drives cardiovascular, metabolic and neurodegenerative disease through a shared axis. It is trackable with cheap blood tests, and in more than three thousand older adults a plain seven-marker inflammation score out-predicted thirteen epigenetic clocks for four-year mortality. Most importantly, it responds to ordinary levers. A Mediterranean-pattern diet, sustained calorie restriction and regular well-recovered exercise have measurably lowered inflammatory markers in trials; omega-3s, fibre, sleep and stress reduction act on the same machinery, with the evidence resting more on mechanism than on demonstrated marker reductions.

What it doesn't tell you: that any drug or supplement should be used to suppress inflammation for longevity in a healthy person. The pharmacological agents are promising but unproven for that purpose — TAME has never enrolled anyone, and PEARL missed its primary endpoint. It also does not tell you that lowering a marker lowers your risk: almost all of the intervention evidence shows behaviours moving markers, not markers moving outcomes. Fasting's anti-inflammatory effect appears to ride mostly on fat loss rather than the schedule itself. And inflammation is not simply "bad" — the acute, resolving kind is essential, and the goal is to restore its off-switch, not to abolish it. As with the other hallmarks, the elegance of the mechanism runs well ahead of the proven interventions, and the proven interventions are the unglamorous ones.